Celebrex Acute Pain Claim Limited To Dental Surgery Could Be Considered
Executive Summary
A specific indication for relief of post-dental surgical pain is an option FDA may consider for Searle/Pfizer's COX-2 inhibitor Celebrex, in lieu of a broader acute pain indication.